Expression of complement system components during aging and amyloid deposition in APP transgenic mice

Expression of complement system components during aging and amyloid deposition in APP transgenic mice

<p>Abstract</p> <p>Background</p> <p>A causal role of the complement system in Alzheimer's disease pathogenesis has been postulated based on the identification of different activated components up to the membrane attack complex at amyloid plaques in brain. However,...

Full description

Bibliographic Details
Main Authors:	Wiederhold Karl-Heinz, Danner Simone, Reichwald Julia, Staufenbiel Matthias
Format:	Article
Language:	English
Published:	BMC 2009-11-01
Series:	Journal of Neuroinflammation
Online Access:	http://www.jneuroinflammation.com/content/6/1/35

Similar Items

Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23)
by: Margarita Diez, et al.
Published: (2003-12-01)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
by: Johannes Steffen, et al.
Published: (2017-06-01)

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice
by: Elena M. Ribé, et al.
Published: (2005-12-01)

Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
by: Thomas van Groen, et al.
Published: (2006-09-01)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
by: Freeman Melissa J, et al.
Published: (2005-02-01)

Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
by: Gordon Marcia N, et al.
Published: (2004-12-01)

Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
by: Eric A Tanifum, et al.
Published: (2012-01-01)

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
by: Walter Jochen, et al.
Published: (2005-10-01)

Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype.
by: Isobel J Whitehouse, et al.
Published: (2016-01-01)

Chronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice
by: Kitaguchi, Hiroshi
Published: (2010)

Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice
by: Tarja M. Malm, et al.
Published: (2005-02-01)

VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.
by: Min Song, et al.
Published: (2012-01-01)

Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice
by: Gang Luo, et al.
Published: (2016-01-01)

Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain
by: Dieter Lütjohann, et al.
Published: (2002-07-01)

Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
by: Nikisha Carty, et al.
Published: (2013-01-01)

Infrared microspectroscopy of focally elevated creatine in brain tissue from amyloid precursor protein (APP) transgenic mice
by: Gallant, Meghan
Published: (2008)

Infrared microspectroscopy of focally elevated creatine in brain tissue from amyloid precursor protein (APP) transgenic mice
by: Gallant, Meghan
Published: (2008)

Infrared microspectroscopy of focally elevated creatine in brain tissue from amyloid precursor protein (APP) transgenic mice
by: Gallant, Meghan
Published: (2008)

The effect of peripheral LPS-induced neuroinflammation on the beta-amyloid plaque formation in APP/PS1 transgenic mice
by: Yan-Ru Lee, et al.
Published: (2009)

Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
by: Jun Wang, et al.
Published: (2003-12-01)

SRC-1 Knockout Exerts No Effect on Amyloid β Deposition in APP/PS1 Mice
by: Qiong Wu, et al.
Published: (2020-06-01)

Complement Association with Neurons and β-Amyloid Deposition in the Brains of Aged Individuals with Down Syndrome
by: Elizabeth Head, et al.
Published: (2001-04-01)

In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice.
by: Jose Morales-Corraliza, et al.
Published: (2009-09-01)

X11α haploinsufficiency enhances Aβ amyloid deposition in Alzheimer's disease transgenic mice
by: Inderjeet Saluja, et al.
Published: (2009-10-01)

Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
by: Adrian C. Lo, et al.
Published: (2013-02-01)

Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes
by: E. McGowan, et al.
Published: (1999-08-01)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
by: Pengcheng Geng, et al.
Published: (2018-07-01)

Continuation of exercise is necessary to inhibit high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice.
by: Masato Maesako, et al.
Published: (2013-01-01)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
by: Emily B. Button, et al.
Published: (2019-05-01)

The Influence of Amyloid-Beta, a Major Pathological Marker in Alzheimer's Disease, on Molecular Cognitive Processes of APP+PS1 Transgenic Mice
by: Dickey, Chad Anthony
Published: (2004)

Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
by: Iván Carrera, et al.
Published: (2013-01-01)

Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
by: Ivan Carrera, et al.
Published: (2014-03-01)

Studies of the amyloid precursor protein in cultured cells and transgenic mice
by: Holliman, Damian
Published: (1996)

Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2.
by: Thomas P Griener, et al.
Published: (2011-01-01)

TRANSGENIC STRATEGY FOR IDENTIFYING SYNAPTIC CONNECTIONS IN MICE BY FLUORESCENCE COMPLEMENTATION (GRASP)
by: Masahito eYamagata, et al.
Published: (2012-02-01)

Investigating the effect of components of Antrodia camphorata on attenuating Alzheimer's disease pathology in APP/PS1 transgenic mice
by: Chuan-Sheng Chiu, et al.
Published: (2018)

Amyloid beta deposition related retinal pigment epithelium cell impairment and subretinal microglia activation in aged APPswePS1 transgenic mice
by: Zhi-Zhang Dong, et al.
Published: (2018-05-01)

Effects of (-)epicatechin on the pathology of APP/PS1 transgenic mice
by: Yueqin eZeng, et al.
Published: (2014-05-01)

Memory Deficits in APP23/ Mice Correlate with the Level of A Oligomers
by: Iliya Lefterov, et al.
Published: (2009-03-01)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
by: Diana Klakotskaia, et al.
Published: (2018-01-01)

Cannot write session to /tmp/vufind_sessions/sess_f5bjt571q4d4t73kac4d9kesss